NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
Back to search
Official data from USPTO
BELYOND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/09/2025
Trademark type
Word
Nice classes
5
Filing date
11/28/2023
Registration date
12/09/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Carrigtohill, Co. Cork, IE
Examiner
CROSS, TRACY L
Law office
L90
Current location
INTENT TO USE SECTION
Holders and representatives
Holders
G. U. (pessoa física)
Representatives
Jack Wessel GILEAD SCIENCES, INC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/17/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/14/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/24/2025
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
07/24/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/09/2025
EX1G
SOU EXTENSION 1 GRANTED
07/08/2025
EXT1
SOU EXTENSION 1 FILED
07/08/2025
EEXT
SOU TEAS EXTENSION RECEIVED
07/08/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2024
PUBO
PUBLISHED FOR OPPOSITION
12/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/18/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2024
ALIE
ASSIGNED TO LIE
11/22/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/27/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/27/2024
GNSL
LETTER OF SUSPENSION E-MAILED
06/27/2024
CNSL
SUSPENSION LETTER WRITTEN
06/27/2024
DOCK
ASSIGNED TO EXAMINER
06/26/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/22/2024
NWAP
NEW APPLICATION ENTERED
12/01/2023
Continuous trademark protection
Get notified about every new filing that threatens BELYOND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.